Neuraptive Therapeutics
Phase 3Neuraptive is developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
Founded
2017
Focus
NeuroscienceRegenerative Medicine
About
Neuraptive is developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries.
Funding History
2Total raised: $25M
Series A$20MUndisclosedMar 15, 2021
Seed$5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationPhiladelphia, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile